nefopam

This page covers all nefopam drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C.

Targets

5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C

Marketed (1)

• Fenazoxine · Pain
  Nefopam works by blocking the sodium-dependent serotonin transporter, which helps regulate pain perception in the brain.

Patent intelligence

• nefopam patent landscape — aggregated cliff calendar, attackable patents, originator estates